5,235 followers
RT @DrImranSheikh: Young patients show poor efficacy for immune checkpoint inhibitor combined therapy in metastatic gastrointestinal cancer…
RT @DrImranSheikh: Young patients show poor efficacy for immune checkpoint inhibitor combined therapy in metastatic gastrointestinal cancer…
Young patients show poor efficacy for immune checkpoint inhibitor combined therapy in metastatic gastrointestinal cancers https://t.co/vZ5CV7SgOm https://t.co/bKRl1bAi8A
New research: Young patients show poor efficacy for immune checkpoint inhibitor combined therapy in metastatic gastrointestinal cancers: Background The impact of age on the efficacy and safety of immunotherapy remains controversial. The… #oncology https:/